Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Virtual Clinical Trials Market, by Study Type
1.4.2 Europe Virtual Clinical Trials Market, by Indication
1.4.3 Europe Virtual Clinical Trials Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Geographical Expansions
3.2.4 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2017, Oct – 2020, Nov) Leading Players
3.3.3 Key Strategic Move: (Product Launches and Product Expansions : 2018, Jun – 2020, Oct) Leading Players
Chapter 4. Europe Virtual Clinical Trials Market by Study Type
4.1 Europe Interventional Market by Country
4.2 Europe Observational Market by Country
4.3 Europe Expanded Access Market by Country
Chapter 5. Europe Virtual Clinical Trials Market by Indication
5.1 Europe Oncology Market by Country
5.2 Europe Cardiovascular Market by Country
5.3 Europe Immunology Market by Country
5.4 Europe Gastrointestinal Market by Country
5.5 Europe Respiratory Market by Country
5.6 Europe Endocrinology Market by Country
5.7 Europe Ophthalmology Market by Country
5.8 Europe Other Indications Market by Country
Chapter 6. Europe Virtual Clinical Trials Market by Country
6.1 Germany Virtual Clinical Trials Market
6.1.1 Germany Virtual Clinical Trials Market by Study Type
6.1.2 Germany Virtual Clinical Trials Market by Indication
6.2 UK Virtual Clinical Trials Market
6.2.1 UK Virtual Clinical Trials Market by Study Type
6.2.2 UK Virtual Clinical Trials Market by Indication
6.3 France Virtual Clinical Trials Market
6.3.1 France Virtual Clinical Trials Market by Study Type
6.3.2 France Virtual Clinical Trials Market by Indication
6.4 Russia Virtual Clinical Trials Market
6.4.1 Russia Virtual Clinical Trials Market by Study Type
6.4.2 Russia Virtual Clinical Trials Market by Indication
6.5 Spain Virtual Clinical Trials Market
6.5.1 Spain Virtual Clinical Trials Market by Study Type
6.5.2 Spain Virtual Clinical Trials Market by Indication
6.6 Italy Virtual Clinical Trials Market
6.6.1 Italy Virtual Clinical Trials Market by Study Type
6.6.2 Italy Virtual Clinical Trials Market by Indication
6.7 Rest of Europe Virtual Clinical Trials Market
6.7.1 Rest of Europe Virtual Clinical Trials Market by Study Type
6.7.2 Rest of Europe Virtual Clinical Trials Market by Indication
Chapter 7. Company Profiles
7.1 IQVIA Holdings, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Recent strategies and developments:
7.1.4.1 Partnerships, Collaborations, and Agreements:
7.1.4.2 Product Launches and Product Expansions:
7.2 ICON PLC
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.1 Recent strategies and developments:
7.2.1.1 Partnerships, Collaborations, and Agreements:
7.2.1.2 Product Launches and Product Expansions:
7.2.1.3 Acquisition and Mergers:
7.3 Laboratory Corporation of America Holdings (Covance, Inc.)
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Recent strategies and developments:
7.3.4.1 Product Launches and Product Expansions:
7.3.4.2 Acquisition and Mergers:
7.4 Dassault Systemes SE (Medidata Solutions, Inc.)
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Partnerships, Collaborations, and Agreements:
7.4.5.2 Product Launches and Product Expansions:
7.4.5.3 Acquisition and Mergers:
7.5 Oracle Corporation
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Partnerships, Collaborations, and Agreements:
7.5.5.2 Product Launches and Product Expansions:
7.6 Parexel International Corporation (Pamplona Capital Management)
7.6.1 Company Overview
7.6.2 Recent strategies and developments:
7.6.2.1 Partnerships, Collaborations, and Agreements:
7.6.2.2 Product Launches and Product Expansions:
7.6.2.3 Geographical Expansions:
7.7 PRA Health Sciences, Inc. (KKR & Co., Inc.)
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental Analysis
7.7.4 Recent strategies and developments:
7.7.4.1 Partnerships, Collaborations, and Agreements:
7.7.4.2 Product Launches and Product Expansions:
7.8 Medpace Holdings, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Recent strategies and developments:
7.8.3.1 Partnerships, Collaborations, and Agreements:
7.9 Medable, Inc.
7.9.1 Company Overview
7.9.2 Recent strategies and developments:
7.9.2.1 Partnerships, Collaborations, and Agreements:
7.9.2.2 Product Launches and Product Expansions:
7.10. Clinical Ink, Inc. (G.I. Partners)
7.10.1 Company Overview
7.10.2 Recent strategies and developments:
7.10.2.1 Partnerships, Collaborations, and Agreements:
Unique Offerings 
